206 related articles for article (PubMed ID: 33534038)
1. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
[TBL] [Abstract][Full Text] [Related]
2. Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma.
Qi Q; Fox MS; Lim H; Sullivan R; Li A; Bellyou M; Desjardins L; McClennan A; Bartha R; Hoffman L; Scholl TJ; Lee TY; Thiessen JD
Mol Imaging Biol; 2023 Apr; 25(2):271-282. PubMed ID: 36418769
[TBL] [Abstract][Full Text] [Related]
3. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
[TBL] [Abstract][Full Text] [Related]
5. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Early Changes in Tumor Metabolism in Response to Therapy Using Hyperpolarized
Lim H; Martínez-Santiesteban F; Jensen MD; Chen A; Wong E; Scholl TJ
Tomography; 2020 Sep; 6(3):290-300. PubMed ID: 32879899
[TBL] [Abstract][Full Text] [Related]
7. Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
Datta K; Lauritzen MH; Merchant M; Jang T; Liu SC; Hurd R; Recht L; Spielman DM
PLoS One; 2019; 14(12):e0225313. PubMed ID: 31830049
[TBL] [Abstract][Full Text] [Related]
8. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
An YS; Kang DK; Jung YS; Han S; Kim TH
Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous characterization of tumor cellularity and the Warburg effect with PET, MRI and hyperpolarized
Hundshammer C; Braeuer M; Müller CA; Hansen AE; Schillmaier M; Düwel S; Feuerecker B; Glaser SJ; Haase A; Weichert W; Steiger K; Cabello J; Schilling F; Hövener JB; Kjær A; Nekolla SG; Schwaiger M
Theranostics; 2018; 8(17):4765-4780. PubMed ID: 30279736
[TBL] [Abstract][Full Text] [Related]
10. Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging.
Day SE; Kettunen MI; Cherukuri MK; Mitchell JB; Lizak MJ; Morris HD; Matsumoto S; Koretsky AP; Brindle KM
Magn Reson Med; 2011 Feb; 65(2):557-63. PubMed ID: 21264939
[TBL] [Abstract][Full Text] [Related]
11. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
Capozza M; Anemone A; Dhakan C; Della Peruta M; Bracesco M; Zullino S; Villano D; Terreno E; Longo DL; Aime S
Mol Imaging Biol; 2022 Feb; 24(1):126-134. PubMed ID: 34383241
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-
van Heijster FHA; Heskamp S; Breukels V; Veltien A; Franssen GM; Jansen KCFJ; Boerman OC; Schalken JA; Scheenen TWJ; Heerschap A
NMR Biomed; 2020 Oct; 33(10):e4362. PubMed ID: 32662543
[TBL] [Abstract][Full Text] [Related]
13. Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Seligman L; Kovanlikaya I; Pisapia DJ; Naeger DM; Magge R; Fine HA; Chiang GC
AJR Am J Roentgenol; 2019 Apr; 212(4):883-891. PubMed ID: 30779663
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks TI; von Eyben R; Hristov D; Kidd EA
Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
[TBL] [Abstract][Full Text] [Related]
15. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
Bisdas S; Spicer K; Rumboldt Z
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1376-81. PubMed ID: 18483187
[TBL] [Abstract][Full Text] [Related]
16. Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion.
Janssen MH; Aerts HJ; Buijsen J; Lambin P; Lammering G; Öllers MC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):849-55. PubMed ID: 21392896
[TBL] [Abstract][Full Text] [Related]
17. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
Sacconi B; Raad RA; Lee J; Fine H; Kondziolka D; Golfinos JG; Babb JS; Jain R
J Neurooncol; 2016 Apr; 127(2):287-93. PubMed ID: 26729270
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.
Gutte H; Hansen AE; Larsen MM; Rahbek S; Henriksen ST; Johannesen HH; Ardenkjaer-Larsen J; Kristensen AT; Højgaard L; Kjær A
J Nucl Med; 2015 Nov; 56(11):1786-92. PubMed ID: 26338899
[TBL] [Abstract][Full Text] [Related]
19. Volumetric spiral chemical shift imaging of hyperpolarized [2-(13) c]pyruvate in a rat c6 glioma model.
Park JM; Josan S; Jang T; Merchant M; Watkins R; Hurd RE; Recht LD; Mayer D; Spielman DM
Magn Reson Med; 2016 Mar; 75(3):973-84. PubMed ID: 25946547
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
